GlassScriptPhysician profile
Shane M Hodge
NPI 1548498975
$1,435.51
in general payments reported to CMS, 2019-2025
20 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,012 · 2020: $30.57 · 2023: $67.02 · 2024: $203 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $791.61 | 2019 | |
| Davol INC. | $162.50 | 2019-2025 | Phasix Mesh |
| Coloplast Corp | $78.18 | 2024 | |
| Kci USA, INC. | $63.57 | 2019-2023 | Promogran Prisma, Tegaderm, Kerramax Care |
| Becton, Dickinson and Company | $49.35 | 2024 | Arista Ah Flexitip |
| Tela Bio, INC. | $45.15 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $33.29 | 2019-2023 | Harmonic |
| Stryker Corporation | $28.57 | 2024 | Molli |
| Elucent Medical | $25.61 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $22.67 | 2019 | |
| Mimedx Group, INC. | $19.75 | 2025 | |
| Organogenesis INC. | $18.86 | 2024 | |
| Smith+Nephew, INC. | $16.91 | 2019 | |
| Teleflex LLC | $14.98 | 2019 | |
| Hologic Sales and Service, LLC | $14.35 | 2024 | Coolseal Generator |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $13.92 | 2024 | Myrisk |
| Optinose US, INC. | $12.97 | 2019 | |
| Endogastric Solutions, INC | $12.46 | 2023 | Esophyx |
| Tei Biosciences INC | $10.81 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$150,003.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Hodge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.